ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)
China · Delayed Price · Currency is CNY 30.49
+1.17 (3.99%)
At close: Sep 30, 2026
ChengDa Pharmaceuticals Revenue
ChengDa Pharmaceuticals had revenue of 127.25M CNY in the quarter ending June 30, 2026, with 19.88% growth. This brings the company's revenue in the last twelve months to 479.41M, up 36.36% year-over-year. In the year 2025, ChengDa Pharmaceuticals had annual revenue of 406.37M with 21.99% growth.
Revenue (ttm)
479.41M
Revenue Growth
+36.36%
P/S Ratio
9.63
Revenue / Employee
690.79K
Employees
694
Market Cap
4.62B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 406.37M | 73.24M | 21.99% |
| Dec 31, 2024 | 333.13M | -81.17M | -19.59% |
| Dec 31, 2023 | 414.30M | 2.84M | 0.69% |
| Jan 1, 2023 | 411.46M | -4.26M | -1.03% |
| Jan 1, 2022 | 415.73M | 42.69M | 11.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.